Credit Suisse Ag Eli Lilly & CO Call Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $9.92 Million - $12.3 Million	-44,100 Reduced 23.38%	144,500 $39.9 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $842,080 - $1.04 Million	-3,800 Reduced 1.98%	188,600 $43.6 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $6.08 Million - $7.87 Million	33,700 Added 21.24%	192,400 $44.1 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $14.9 Million - $19.3 Million	90,700 Added 133.38%	158,700 $29.6 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $3.86 Million - $5.11 Million	-29,600 Reduced 30.33%	68,000 $11.5 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $2.03 Million - $2.35 Million	13,900 Added 16.61%	97,600 $14.4 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $7.94 Million - $9.56 Million	58,200 Added 228.24%	83,700 $13.7 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $3.71 Million - $4.6 Million	-31,200 Reduced 55.03%	25,500 $3.54 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $1.35 Million - $1.46 Million	-12,600 Reduced 18.18%	56,700 $6.34 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $7.8 Million - $9.1 Million	-70,400 Reduced 50.39%	69,300 $7.68 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $21 Million - $24.7 Million	-188,800 Reduced 57.47%	139,700 $18.1 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $14.2 Million - $15.9 Million	-133,900 Reduced 28.96%	328,500 $38 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $25 Million - $31.3 Million	291,700 Added 170.88%	462,400 $49.6 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $3.79 Million - $4.34 Million	50,000 Added 41.43%	170,700 $14.6 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $5.25 Million - $6.19 Million	70,700 Added 141.4%	120,700 $9.34 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.85 Million - $4.28 Million	50,000	50,000 $4.28 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account